NCT07781306Recruiting
PrOspEctive Metastases Imaging (POEM)
Prospective Complete Histopathological Characterization of Liver Metastases From Colorectal and Breast Carcinoma to Predict the Histopathological Growth Patterns by Medical Imaging - PrOspEctive Metastases Imaging (POEM)
Source: ClinicalTrials.gov · Last updated 24 Aug 2026
Brief summary (registry, in English)
This is a non-interventional, observational study with an optional interventional biobanking activity. Liver metastases of patients undergoing partial hepatectomy will be sampled completely while respecting the orientation used for medical imaging, in order to correlate the histopathological growth patterns in a 3D-map with the imaging characteristics. The full pathological sampling will only use remnant tissue.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 15 Feb 2021
- Start date
- 8 Sept 2020
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Cancer Research Antwerp
- Diseases
- Colorectal cancer
- NCT number
- NCT07781306
What you commit to
- Study type: Observational
- Planned participants: 50
- From 8 Sept 2020 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients without MRI or CT of the liver prior to surgery
- Prior radiofrequency ablation (RFA) or transarterial chemoembolization (TACE) on the liver metastasis that would be operated
Other
- Time interval between medical imaging, CT and/or MRI is more than 12 weeks (nb: time interval is preferably less than 4 weeks but this is not an exclusion criterium)
Who the study is looking for
- ≥ 18 years old.
- Patients with liver metastatic colorectal or breast carcinoma undergoing a surgical excision of the liver metastases
- Therapy-naive patients as well as patients with neo-adjuvant therapy are eligible for inclusion
- Willingness of the patient to participate in this study demonstrated by signed written informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| GZA St Augustinus Coordinator of this site? Confirm its status | Wilrijk | Belgium | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.